Pharma M&A versus alliances and its underlying value drivers : are M&A or alliances the right therapy for an ailing pharmaceutical industry? : a capital market perspective
著者
書誌事項
Pharma M&A versus alliances and its underlying value drivers : are M&A or alliances the right therapy for an ailing pharmaceutical industry? : a capital market perspective
（Corporate finance and governance, Bd. 15）
PL Academic Research, c2015
大学図書館所蔵 件 / 全1件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references (p. 183-199)
内容説明・目次
内容説明
From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.
目次
Contents: The Pharmaceutical Industry and its Paradigm Shift - The Pharmaceutical Industry and Mergers & Acquisitions - Value Creation in Pharmaceutical M&A and its underlying Value Drivers - The Pharmaceutical Industry and Alliances - Value Creation in Pharmaceutical In-licensings and its underlying Value Drivers - M&A versus In-licensing.
「Nielsen BookData」 より
